Financhill
Back

Seritage Growth Properties Vs. Monopar Therapeutics Industry Stock Comparison

Sell
19

SRG
Seritage Growth Properties

Last Price:
$3.31
Seasonality Move:
-1.12%
Sell
43

MNPR
Monopar Therapeutics

Last Price:
$41.00
Seasonality Move:
-14.17%
Sell
19
Seritage Growth Properties (SRG) is a Sell

Is Seritage Growth Properties a Buy, Sell or Hold?

  • The current Seritage Growth Properties [SRG] share price is $3.31. The Score for SRG is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • SRG is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Monopar Therapeutics (MNPR) is a Sell

Is Monopar Therapeutics a Buy, Sell or Hold?

  • The current Monopar Therapeutics [MNPR] share price is $38.10. The Score for MNPR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRG Stock Price Chart

What is Seritage Growth Properties's stock price today?

  • The Seritage Growth Properties share price today is $3.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRG is experiencing slight buying pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics's stock price today?

  • The Monopar Therapeutics share price today is $38.10
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 41.45 Sell
Chaikin Money Flow: 7043 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.32 - 3.74) Sell
Bollinger Bands (100): (3.58 - 4.3) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.51 Buy
Relative Strength Index (14 RSI): 53.92 Buy
Chaikin Money Flow: 16104 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.92 - 40.18) Buy
Bollinger Bands (100): (19.15 - 39.21) Buy

SRG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.42 Sell
20-day SMA: 3.45 Sell
50-day SMA: 3.64 Sell
200-day SMA: 4.3 Sell
8-day EMA: 3.38 Sell
20-day EMA: 3.46 Sell
50-day EMA: 3.64 Sell
200-day EMA: 4.68 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.22 Sell
20-day SMA: 33.78 Buy
50-day SMA: 37.25 Buy
200-day SMA: 16.69 Buy
8-day EMA: 37.42 Buy
20-day EMA: 36.3 Buy
50-day EMA: 34.68 Buy
200-day EMA: 21.35 Buy

Seritage Growth Properties Earnings Growth & SRG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.

Seritage Growth Properties Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):